Global Cardiac Mapping Market

Cardiac Mapping Market size was valued at US$ 472 Mn in 2022 and the total revenue is expected to grow at 5.7 % through 2022 to 2029, reaching nearly US$ 695.79 Mn in the forecast period.

Cardiac Mapping Market Overview:

Cardia mapping is a process of identifying the temporal and special distribution of myocardial electric potential during a particular heart rhythm. Mapping particularly refers to clarification of the working system of the heart or to understand the cardiac rhythm. Cardia mapping is a broad term that is responsible to cover various modes of mapping like body surface, endocardial, and epicardial mapping, etc. To know about the Research Methodology :- Request Free Sample Report

Cardiac Mapping Market Dynamics:

Cardiac mapping is used to differentiate the functions of normal and abnormal heart rates to offer precise diagnostic treatment and observe arrhythmia to offer precise treatment. 3D technology is likely to boost the growth of the market in the forecast period. As the technology offers an exact location in the heart to implant a catheter. As catheters are responsible to improve cardiac actions and diagnosing abnormal conditions like arrhythmia.

Growing technologies is likely to boost the growth of the market in the forecast period. As the latest technologies are entering the market to offers rapid results, improved efficacy and accuracy to offer the treatment, and covering arrhythmia as compared to old treatment options. The latest technologies are launched with low exposure to ionizing radiation (fluoroscopy) with the help of non-fluoroscopy catheter navigation. The advancement in the technology is likely to boost the market as the technologies allow quicker detection of complex arrhythmia and reduce diagnostic errors. These factors are likely to stimulate the adoption of technologies by the physicians in the hospitals to offer better treatment options worth expenses to the patient. Hence, these factors are like to uplift the market.

Rate cardiovascular diseases (CVD) is estimated to fuel the growth of the market. As per World Health Organization (WHO) in 2021, the rate of cardiac diseases causing fatality is around 17.9 million with 33% of deaths globally. And the majority of death were in the middle-class population due to a lack of treatment options. additionally, around 600,000 individuals in the US are died due to cardiac diseases. This fatality rate is estimated to motivate the growth of the cardiac mapping market.

Further, partnerships are playing important role in the market as a business strategy to sustain in the market. For instance- in 2021 Acutuc Medical collaborated with peerbride health to offer Advanced ambulatory ECG-peerbridge Cor.

Cardiac Mapping Market Segment Analysis:

The Contact Cardiac Mapping Systems segment is supplementing the growth of the Global Cardiac Mapping Market.

Contact Cardiac mapping system is dominating the global cardiac mapping market and is projected to grow at the highest rate during the forecast period with the largest revenue share of 47.3% in 2022. The segment is divided by electroanatomical mapping, basket catheter mapping, traditional endocardial mapping. The growth of the segment is driven by benefits offered by the contact cardiac mapping like detection of location with accuracy, ablation catheter in a 3-dimension environment together with multi-electrode basket catheter. Moreover, recording of few seconds of the heartbeat is enough to uncover the arrhythmia circuit. These factors are likely to boost the market of contact cardiac mapping segment of the global cardiac mapping market. Moreover, the launching of a new system for cardiac mapping is likely to boost the growth of the market in the forecast period.

The Atrial fibrillation segment is Trending in the Indication Segment of the Global Cardiac Mapping Market.

Atrial fibrillation is held the largest market share in the indication segment of the global cardiac mapping market. Atrial fibrillation is a term that describes irregular and rapid heart rate that is responsible to increase heart rate and heart-related complications. The major concerns with atrial fibrillation are the potential to develop clots in the upper chamber of the heart and this clot may travel to the other organs of the body and can lead to blockage and a person may suffer from severe heart attacks or deaths at times.

Atrial fibrillations are a major indication for heart illness hence this can be prevented in a particular period. Additionally, growing obesity, irregular exercise, unhealthy diets, and lifestyle patterns are the factors hitting the growth of atrial fibrillation and may lead to heart illness. Moreover, the growing geriatric population is likely to supplement the growth of the market.

Cardiac Mapping Market Regional Insights:

The Cardiac Mapping market is regionally segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

North America is dominating the global Cardiac Mapping market with 37.9% of the market share. The growth of North America is attributed to the rising approvals from the governments for various mapping systems and clinical trials validating cardiac mapping systems. As it is necessary to pass through regulatory standards and guidelines imposed by the government of the US. Further rising cardiovascular diseases, like heart attacks, cardiac arrest, irregular heart rhythm are anticipated to hit the growth of the regional market.

Moreover, rising funding and healthcare programs by the government of the US. Is likely to fuel the growth of the market in the forecast period. The dominating countries of North America are the US, Canada, and Mexico. Further, the geriatric population in Canada is estimated to drive the growth of regions of the market during the forecast period. Besides, market players are entering the market to enhance the growth of the market in terms of developed technologies and the healthcare system.

Rising mergers and acquisitions are anticipated to hit the market growth. For instance, in 2021 Acutus Medical announced a strategic partnership with Peerbridge Health, Cardiac Designs, and MedFact to offer solutions access therapy, diagnostics, and rhythm monitoring.

The objective of the report is to present a comprehensive analysis of the Global Cardiac Mapping Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Cardiac Mapping Market dynamics, structure by analyzing the market segments and project the Global Cardiac Mapping Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Cardiac Mapping Market make the report investor’s guide.

Global Cardiac Mapping Market Scope: Inquire before buying

Cardiac Mapping Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Cardiac Mapping Market Key Players are:

1. Biosense Webster (US)
2. Abbott (US)
3. Boston Scientific Corporation (US)
4. Medtronic (Ireland)
5. MicroPort Scientific Corporation (China)
6. EP Solutions SA (Switzerland)
7. Acutus Medical (US)
8. Koninklijke Philips N.V. (Royal Philips) (Netherlands)
9. Lepu Medical (China)
10.BIOTRONIK (Germany)
11.AngioDynamics (US)
12.BioSig Technologies (US)
13.APN Health (US)
14.CoreMap (US)
15.Kardium (Canada)
16.Catheter Precision (US)
17.Epmap-System (Germany)

FAQs:

1. What is the global Cardiac Mapping market value in 2022?
Ans: Global Cardiac Mapping Market size was valued at US$ 472 Mn in 2022 and is estimated to grow further in the forecast period.

2. What is the global Cardiac Mapping market growth?
Ans: The global market is anticipated to grow with a CAGR of 5.7% in the forecast period and is likely to reach 695.79 million by the end of 2029.

3. Which product segment is expected to dominate the global Cardiac Mapping market during the forecast period?
Ans: The contact cardiac mapping segment dominated the market for Cardiac Mapping and held the largest revenue share of 47.3% in 2022

4. Who are the key players in the Cardiac Mapping market?
Ans: Some key players operating in the market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US), Medtronic (Ireland), MicroPort Scientific Corporation (China)

5. What is the key driving factor for the growth of the global Cardiac Mapping market?
Ans: Key factors that are driving the market growth involve new entrants in the market, growing investment, funds, and grants, and the growing prevalence of chronic diseases.